In Vitro Conditioning of Adipose-Derived Mesenchymal Stem Cells by the Endothelial Microenvironment: Modeling Cell Responsiveness towards Non-Genetic Correction of Haemophilia A
Authors:
- Silvia BarbonSilvia Barbon
- Elena StoccoElena Stocco
- Senthilkumar RajendranSRSenthilkumar Rajendran
- Lorena ZardoLZLorena Zardo
- Veronica MacchiVeronica Macchi
- Claudio GrandiCGClaudio Grandi
- Giuseppe TagarielloGTGiuseppe Tagariello
- Andrea PorzionatoAndrea Porzionato
- Paolo RadossiPRPaolo Radossi
- Raffaele De CaroRaffaele De Caro
- Pier Paolo ParnigottoPPPier Paolo Parnigotto
Open Access
- 30 June 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (13) , 7282
Abstract
In recent decades, the use of adult multipotent stem cells has paved the way for the identification of new therapeutic approaches for the treatment of monogenic diseases such as Haemophilia A. Being already studied for regenerative purposes, adipose-derived mesenchymal stem cells (Ad-MSCs) are still poorly considered for Haemophilia A cell therapy and their capacity to produce coagulation factor VIII (FVIII) after proper stimulation and without resorting to gene transfection. In this work, Ad-MSCs were in vitro conditioned towards the endothelial lineage, considered to be responsible for coagulation factor production. The cells were cultured in an inductive medium enriched with endothelial growth factors for up to 21 days. In addition to significantly responding to the chemotactic endothelial stimuli, the cell populations started to form capillary-like structures and up-regulated the expression of specific endothelial markers (CD34, PDGFRα, VEGFR2, VE-cadherin, CD31, and vWF). A dot blot protein study detected the presence of FVIII in culture media collected from both unstimulated and stimulated Ad-MSCs. Remarkably, the activated partial thromboplastin time test demonstrated that the clot formation was accelerated, and FVIII activity was enhanced when FVIII deficient plasma was mixed with culture media from the untreated/stimulated Ad-MSCs. Overall, the collected evidence supported a possible Ad-MSC contribution to HA correction via specific stimulation by the endothelial microenvironment and without any need for gene transfection.Keywords
Funding Information
- liberathe relative quantification methol donations from T.E.S. Foundation, Padova, Italy
This publication has 62 references indexed in Scilit:
- Role of bone marrow transplantation for correcting hemophilia A in miceBlood, 2012
- Angiogenic efficacy of Heparin on chick chorioallantoic membraneVascular Cell, 2012
- Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSCExperimental Hematology, 2011
- Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A miceThrombosis and Haemostasis, 2011
- Delivery of Factor VIII Gene into Skeletal Muscle Cells Using Lentiviral VectorYonsei Medical Journal, 2010
- Endothelial Differentiation of Adipose-Derived Stem Cells: Effects of Endothelial Cell Growth Supplement and Shear ForceJournal of Surgical Research, 2009
- Phenotypic correction of murine hemophilia A using an iPS cell-based therapyProceedings of the National Academy of Sciences, 2009
- Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A miceJournal of Clinical Investigation, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001